ZY Therapeutics
2015
FOUNDED
PRIVATE
STATUS
Angel
LATEST DEAL TYPE
$6M
LATEST DEAL AMOUNT
Description
Operator of a drug development company. The company specializes in pharmacotherapeutics and novel delivery models for developing therapeutics and drugs to improve the lives of patients suffering from rare and orphan diseases.
Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Drug Delivery
Other Industries
Pharmaceuticals
Drug Discovery
Primary Office
- 12218 Bradford Green Square
- Suite 220
- Cary, NC 27519
- United States
+1 (919) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore ZY Therapeutics’s full profile, request a free trial.
ZY Therapeutics Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Angel (individual) | 14-Jun-2016 | $6M | 000 | Completed | Startup |
ZY Therapeutics Executive Team (3)
| Name | Title | Board Seat |
Contact Info |
|---|---|---|---|
| Jian Bao | Co-Founder & Chief Executive Officer | ||
| Bryan Hill | Founder & Chief Executive Officer | ||
| Jun Li | Executive Officer & Board Member |
ZY Therapeutics Board Members (4)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Jun Li | ZY Therapeutics | Executive Officer & Board Member | 000 0000 | |
| Nan Li | ZY Therapeutics | Board Member | 000 0000 | |
| Yongming Zhang | ZY Therapeutics | Board Member | 000 0000 | |
| Ziyi Wang | ZY Therapeutics | Board Member | 000 0000 |